Interim results highlight six-month outcomes for patients treated with the Sphere-9 catheter for sustained monomorphic ventricular tachycardia (VT)Breakthrough device designation granted for use of th ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results